The world needs to accept that relations between the U.S. and China will never be the same, and ultimately counting on the Fed to cut rates is not going to help fundamentals.
Emotions are running high in this market, and its turbulent relationship with investors will likely go on as we work our way toward oversold.
Low expectations for China-trade talks and uncertainty about Fed action leave traders wary.
Chart patterns suggest the food delivery service company has bottomed out and may be turning.
While many traders side with either bears or bulls, remember to embrace the ebb and flow of markets.
Despite the financial positivity, many analysts warn the deal could have hiccups ahead.
The deal makes sense for growth - and for Allergan shareholders - but now the price and uncertainty make this stock hard to swallow.
With no other bidder expected to emerge, this is a high risk arbitrage play.
PFE was ready to pay $160 billion until U.S. regulators blocked the deal.
Let's look at their price charts and technical indicators, and draw some conclusions.